Filter Results:
(324)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
- 16 Sep 2016
- News
Gaining Ground on ALS
president and CEO of Cytokinetics, Inc., a California-based company that focuses on biology-driven treatments for amyotrophic lateral sclerosis (ALS) and other debilitating diseases associated with muscle weakness. In 2015, the ALS... View Details
- 25 May 2016
- Research & Ideas
How Consumers and Businesses are Reshaping Public Health
commercialization of important new drugs to the detriment of consumers. Interestingly, though, at public hearings, the AstraZeneca chief executive championed the interests of patients in opposing the proposed merger. Consumers worldwide... View Details
- 01 Sep 2004
- News
A Market-Based Prescription
and nephrologist. In a focused factory, all these resources are integrated. These diabetic specialists jointly develop treatment protocols and pricing. Together, they offer a full range of services customized for this disease. Research... View Details
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
by panelist Andy Slavitt (HBS MBA '93), Founder, President and CEO of Healthallies.com, is an exchange that links patients with local health care providers who offer preferred rates. Services include everything from traditional medical procedures to alternative View Details
- Profile
Arjun Goyal
a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical development... View Details
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
iPhoto With billions of dollars spent on the development of precision medicine and related cancer research over the last decade, a recent partnership seeks a new way to bring these treatments to patients more quickly: through a better... View Details
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
The coronavirus crisis forced health care providers to mobilize in ways few could have predicted six months ago, revealing not only the system’s weaknesses but its profound ingenuity. Within weeks, providers worldwide set up drive-through testing sites, makeshift View Details
Keywords: by Danielle Kost
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
interrelated. People who have studied this industry for a long time have come up with a number of feasible ideas to get at the cost problem, including high-deductible insurance and health savings accounts. But until we make sure that the View Details
- 01 Jun 2018
- News
Floor It
The sci-fi future for cancer treatment has become a reality, with breakthrough therapies that can use a cancer patient’s genetic information to create personalized treatments or employ the body’s immune... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 01 Jun 2010
- News
Health IT at the Bedside
prescription from CVS and automatically check for any drug interactions. The hospital, like many community hospitals and doctors’ offices, did not have electronic records, but his office did. Would he ever go back to a paper prescription... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on View Details
- Profile
Henry McCance
drug development, exponentially increasing the chances of finding effective treatment and prevention. In 2004, the three families founded the Cure Alzheimer’s Fund (CAF) to support Tanzi’s work and other... View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
until we make sure that the treatments and services consumers are getting are effective and affordable, changing the way we consumers pay for the services doesn’t fix anything. What we need is a system of new value networks that will... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand the anguish of seriously ill... View Details
- 01 Dec 2013
- News
To Market, to Market
Inhibitors of proteins that play an important role in cholesterol and fat metabolism, to be developed as potential therapeutics for the treatment of diseases such as metabolic syndrome, type 2 diabetes, coronary artery disease, and some... View Details
- 06 Dec 2021
- News
Vision: Sound Science
of scientific inquiry in gene-based hearing loss and inner-ear drug delivery: “In some infants with profound hearing impairment, there’s a mutation in one of those genes that results in loss of a protein that inner-ear cells need to... View Details
Keywords: Deb Blagg
- Profile
Arjun Goyal
“marries a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical... View Details
- 24 Jan 2025
- News
The Network Effect
billion in cash and a 5 percent royalty on the US sales of Tibsovo, a drug used to treat certain types of blood-cell cancer. Mathur started his job at Sagard about the same time. When he saw the news of the deal, he contacted Model. The... View Details
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 01 Mar 2008
- News
The Last Frontier
state for people with debilitating but nonterminal diseases like his to receive, with a doctor’s assistance, drugs with which they may take their own lives. Explained Gardner, “Why do this? I want to be involved in public life. I was... View Details